All In Biotech

Drug Trial Radar · NCT00735462

Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts

A Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts

Last checked: Nov 20, 2026Latest source record: Jul 20, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 511 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

511

Actual

Start

Aug 2008

Primary completion

Jul 2009

Study completion Jul 2009

Sponsor

Lead sponsor
Graceway Pharmaceuticals, LLCIndustry
Sponsor type
Industry
First posted
Aug 15, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether imiquimod creams are effective in treating external genital warts (EGW). The secondary objective of this study is to provide information on recurrence of EGW. Additionally the study will also look at any adverse events associated with the use of the creams. External genital and perianal warts are caused by the infection of human papillomavirus or HPV. HPV infection is a sexually transmitted disease (STD). External genital warts look like small flesh-colored, pink, or red growths on or around the external skin of sex organs or perianal area. The warts may look similar to the small parts of a cauliflower or they may be very tiny and difficult to see. They often appear in clusters of three or four, and may grow and spread rapidly. They usually are not painful, although they may cause mild pain, bleeding, and itching.

Conditions

  • Genital Warts

Interventions

  • 2.5% imiquimod creamDrug

    2.5% imiquimod cream applied daily to wart areas for up to 8 weeks.

  • 3.75% imiquimod creamDrug

    3.75% imiquimod cream applied daily to wart areas for up to 8 weeks

  • Placebo creamDrug

    Placebo cream applied daily to wart areas for up to 8 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Subjects Achieving Complete Clearance of All Warts (Baseline and New) at the End of Study.Time frame: Up to 16 weeks

Locations

43 sites in 1 country. Site status is shown where the registry gives one.

  • NEA Clinic

    Jonesboro, Arkansas

  • Northern Claifornia Research

    Carmichael, California

  • California State University - Chico

    Chico, California

  • Dermatology Research Associates

    Los Angeles, California

  • Conant Foundation

    San Francisco, California

  • Downtown Women's Healthcare

    Denver, Colorado

  • Altus Research

    Lake Worth, Florida

  • PMI Health Research Group

    Atlanta, Georgia

  • Atlanta Women's Research Institute

    Atlanta, Georgia

  • Altman Dermatology Associates

    Arlington Heights, Illinois

  • Howard Brown

    Chicago, Illinois

  • Valley Medical Center

    Flint, Michigan

  • Women's OB/GYN

    Saginaw, Michigan

  • Clayton Research Institute

    St Louis, Missouri

  • Women's Health Research Center

    Lawrenceville, New Jersey

  • Alliance Women's Research

    Riverside Park, New Jersey

  • Southwest Clinical Research

    Albuquerque, New Mexico

  • University Urology Associates

    New York, New York

  • Boro Park ObGyn

    New York, New York

  • Crescent Medical Research

    Salisbury, North Carolina

  • Piedmont Medical Research

    Winston-Salem, North Carolina

  • Rapid Medical Research

    Cleveland, Ohio

  • Complete Healthcare for Women

    Columbus, Ohio

  • Wright State University

    Dayton, Ohio

  • Heartland Health Institute

    Tulsa, Oklahoma

  • Clinical Trials of America

    Eugene, Oregon

  • Westover Heights Clinic

    Portland, Oregon

  • The Clinical Trial Center

    Jenkintown, Pennsylvania

  • Palmetto Clinical Research

    Greer, South Carolina

  • Alpha Clinical Research

    Clarksville, Tennessee

  • Adams Patterson Gynecology and Obstetrics

    Memphis, Tennessee

  • Tennessee Women's Care

    Nashville, Tennessee

  • DiscoveResearch

    Bryan, Texas

  • TMC Life Research

    Houston, Texas

  • West Houston Clinical Research Services

    Houston, Texas

  • Urology San Antonio Research

    San Antonio, Texas

  • The Center for Clinical Studies

    Webster, Texas

  • Utah Clinical Trials

    Salt Lake City, Utah

  • Wasatch Clinical Research

    Salt Lake City, Utah

  • CARE-ID

    Annandale, Virginia

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.